Invention Grant
- Patent Title: Methods for reducing exacerbation rates of asthma using benralizumab
- Patent Title (中): 使用苯那霉素降低哮喘恶化率的方法
-
Application No.: US14453942Application Date: 2014-08-07
-
Publication No.: US09441037B2Publication Date: 2016-09-13
- Inventor: Christine Ward , Lorin Roskos , Bing Wang , Donald Raible
- Applicant: MedImmune, LLC
- Applicant Address: SE Södertälje
- Assignee: ASTRAZENECA AB
- Current Assignee: ASTRAZENECA AB
- Current Assignee Address: SE Södertälje
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K45/06 ; A61K39/395 ; C07K16/24 ; A61K39/00
Abstract:
Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab or an antigen-binding fragment thereof.
Public/Granted literature
- US20150044202A1 METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB Public/Granted day:2015-02-12
Information query
